Drevo Analytics
  • Home
  • Services
    • Competitive Intelligence
    • Market Research
    • Strategic Communications
  • About Us
  • Contact Us
  • Search

Spinifex Pharmaceuticals, a pain drug development company, raises $45MM in Series C financing.

April 12, 2014/in News /by Competitive

Continue reading →

Tags: angiotensin II type 2 receptor antagonist, Brandon Capital Partners, Canaan Partners, chronic pain, GBS Venture Partners, Novo A/S, Phase 2, Series C, UniQuest, Uniseed
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
You might also like
Truveris raises $12.75MM in a Series C financing round led by Canaan Partners to further develop its…

Search

Tags

1st Pitch Life Sciences angiotensin II type 2 receptor antagonist autoimmune disease Best in Show Big Data biotechnology BoxGroup Brandon Capital Partners Canaan Partners Catalyst Health Ventures chronic pain Connecticut Innovations electronic medical records employee health benefits eye-tracking technology First Round flu GBS Venture Partners Google Ventures Harris & Harris Group infectious disease inflammation Lerer Ventures Mid-Atlantic Bio Angels New Atlantic Ventures New Leaf Venture Partners non-dilutive financing non-surgical device Novo A/S oncology Phase 2 prescription benefits protein degradation SaaS Series A Series B Series C Serious Change stress urinary incontinence Tribeca Venture Partners UniQuest Uniseed vaccine Vaizra Investments ventilator-associated pneumonia

Archive of news

  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • January 2014
  • December 2013
  • September 2013
© 2015 All rights reserved - Drevo Analytics, LLC
  • Accessibility
  • Credits
  • Privacy Policy
  • Terms of Use
Connecticut-based Contine Corporation takes the win for Mid Atlantic Bio Angels’... Flatiron Health secures $130MM in Series B round led by Google Ventures.
Scroll to top